Results 171 to 180 of about 735,101 (274)

Immune checkpoint inhibitors for advanced non-small cell lung cancer with poor performance status or older patients. [PDF]

J Thorac Dis
Furuya N.
europepmc   +1 more source

Real-world experience of nivolumab in the treatment of poor performance status patients with advanced non-small cell lung cancer. [PDF]

Cancer Rep (Hoboken), 2022
Abbas MN, Klevansky M, Koczwara B, Roy AC, Sukumaran S, Vatandoust S, Karapetis CS.   +6 more
europepmc   +1 more source

Artificial Intelligence and Mental Well‐Being in Adult Education: Implications for Practice and Professional Responsibility

New Directions for Adult and Continuing Education, EarlyView.
ABSTRACT Mental well‐being is central to adult learner success, yet many adult education institutions lack capacity to provide timely and accessible support. This article examines how artificial intelligence (AI) can strengthen mental health–adjacent supports in adult and continuing higher education, with attention to professional practice and ...
Adam L. McClain, Thomas Wade
wiley   +1 more source

Unexpected Response to Nab-Paclitaxel in Poor Performance Status Lung Adenocarcinoma With a Unique 'Pan-Positive' Tumour Marker Profile: Case Report. [PDF]

Respirol Case Rep
Shimozono M, Kato T, Ohshima N, Kitani M, Maeda M, Nakamura S, Kusaka K, Shimada M, Tamura A.   +8 more
europepmc   +1 more source

Super‐Refractory Status Epilepticus (SRSE) in a Patient With Compound Heterozygous OPA1 Variants: Case Report and Literature Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Super‐Refractory Status Epilepticus (SRSE) is a rare, life‐threatening neurological emergency with unclear etiology in many cases. Mitochondrial dysfunction, often due to disease‐causing genetic variants, is increasingly recognized as a cause, with each gene producing distinct pathophysiological mechanisms.
Pouria Mohammadi, Lara Basovic, Christopher Michael McGraw   +2 more
wiley   +1 more source

Osimertinib opens the door for patients with <i>EGFR</i>-mutated advanced non-small cell lung cancer and a poor performance status: comment on the OPEN/TORG2040 trial. [PDF]

Transl Lung Cancer Res
Fukui T, Naoki K.
europepmc   +1 more source

Immune checkpoint inhibitors in patients with solid tumors and poor performance status: A prospective data from the real-world settings. [PDF]

Medicine (Baltimore), 2021
Kapoor A, Noronha V, Patil VM, Menon N, Joshi A, Abraham G, Prabhash K.   +6 more
europepmc   +1 more source

Spinal Cord Infarction Versus Idiopathic Transverse Myelitis: Clinical, Radiological, and Functional Insights From a Retrospective Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Spinal cord infarction (SCI) is a rare but devastating myelopathy, characterized by a high disability rate and an unfavorable prognosis. It has often been underdiagnosed and misdiagnosed as idiopathic transverse myelitis (ITM). This study aimed to describe the clinical features, radiological biomarkers, treatments, and functional ...
Zeqiang Ji, Jianlong Zhang, Yiming Shi, Shiyu Shan, Yang Du, Guangshuo Li, Ying Jin, Yani Zhang, Chuanying Wang, Yijun Lin, Yuhao Guo, Decai Tian, Xingquan Zhao, Tian Song   +13 more
wiley   +1 more source

Transarterial infusion chemotherapy for severe hepatic dysfunction and poor performance status in diffuse hepatic metastasis: A case report. [PDF]

Oncol Lett
Chen XC, Li XQ, Liu Y, Zhang X, Lin C, Yuan ZP.   +5 more
europepmc   +1 more source

Development and validation of a prediction model of poor performance status and severe symptoms over time in cancer patients (PROVIEW+). [PDF]

Palliat Med, 2021
Seow H, Tanuseputro P, Barbera L, Earle CC, Guthrie DM, Isenberg SR, Juergens RA, Myers J, Brouwers M, Tibebu S, Sutradhar R.   +10 more
europepmc   +1 more source